Your session is about to expire
← Back to Search
Anti-progestin and Prostaglandin
Telehealth for Contraception
N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial explores using a certain pill to help people avoid pregnancy over the next year.
Who is the study for?
This trial is for individuals aged 18-40 who are at risk of unintended pregnancy, not currently pregnant, and would choose to end a pregnancy within the next year. They must be sexually active without permanent contraception or LARC, have regular menstrual cycles, and plan to stay in Oregon or Washington for one year.
What is being tested?
The study tests advanced provision of anti-progestin with prostaglandin via telehealth visits for those who may need it within the next year but do not wish to become pregnant now.
What are the potential side effects?
While specific side effects are not listed here, medications like anti-progestins and prostaglandins can cause cramping, bleeding, nausea, vomiting, diarrhea, headache and fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ enrollment to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of participants reporting satisfaction with the process
The proportion of participants reporting confidence in key steps of taking medications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Telehealth VisitExperimental Treatment1 Intervention
telemedicine visit and follow-up surveys
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
1,006 Previous Clinical Trials
7,413,772 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I would not consider terminating a pregnancy if I became pregnant in the next year.I would choose to end a pregnancy within the next year and prefer not to have an in-office procedure.I am not pregnant and do not plan to become pregnant in the next year.I don't have bleeding disorders, long-term steroid use, porphyria, or allergies to specific medications.I am between 18 and 40 years old.I am between 18 and 40 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Telehealth Visit
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger